English

Isofol Medical

ESEF

Report (type unavailable) · filed 2023-05-09

2 filing records in this dataset, filed from 2022-05-03 to 2023-05-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Segments

Watchlist

Latest fiscal year

Revenue

12.8 million SEK

2022 · SEK

Exact inputs and evidence

Revenue: 12797000 SEK Source

Operating margin

-1,308.59%

2022 · %

Exact inputs and evidence

Operating Income: -167460000 SEK Source
Revenue: 12797000 SEK Source

Operating cash flow

-191 million SEK

2022 · SEK

Exact inputs and evidence

Operating Cash Flow: -190975000 SEK Source

Free cash flow

-191 million SEK

2022 · SEK

Exact inputs and evidence

Operating Cash Flow: -190975000 SEK Source
Capital Expenditure: 0 SEK Source

Cash and cash equivalents: 191 million SEK 2022-12-31 Source
Exact value

190583000 SEK
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-05-09.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2022-12-31
Operating income: 3 of 11 periods available· newest 2022-12-31
Net income: 3 of 11 periods available· newest 2022-12-31
Operating cash flow: 3 of 11 periods available· newest 2022-12-31
Capital expenditure: 3 of 11 periods available· newest 2022-12-31
Total assets: 3 of 11 periods available· newest 2022-12-31
Total liabilities: 3 of 11 periods available· newest 2022-12-31
Current assets: 3 of 11 periods available· newest 2022-12-31
Current liabilities: 3 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2022-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-42.9%

Prior period

SEK 22.41 million

2021-01-01 – 2021-12-31
Current period

SEK 12.8 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

12797000 − 22407000 = -9610000 SEK

22407000 SEK · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
12797000 SEK · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Isofol Medical · 2022-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Year-over-year change in Revenue: -9610000 SEK Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 12797000 SEK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1372971 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 Input fundies:Revenue: 22407000 SEK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1373266 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0
The citation records this snapshot. The page link may show a newer release later.
Net income
+SEK 40.5 million

Prior period

−SEK 200.25 million

2021-01-01 – 2021-12-31
Current period

−SEK 159.76 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-159755000 − -200251000 = 40496000 SEK

-200251000 SEK · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-159755000 SEK · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Isofol Medical · 2022-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Year-over-year change in Net income: 40496000 SEK Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -159755000 SEK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1386843 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 Input fundies:NetIncome: -200251000 SEK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1387180 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−SEK 2.55 million

Prior period

−SEK 188.43 million

2021-01-01 – 2021-12-31
Current period

−SEK 190.98 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-190975000 − -188429000 = -2546000 SEK

-188429000 SEK · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-190975000 SEK · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Isofol Medical · 2022-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Year-over-year change in Operating cash flow: -2546000 SEK Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -190975000 SEK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1453857 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 Input fundies:OperatingCashFlow: -188429000 SEK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1454195 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
SEK 0

Prior period

SEK 0

2021-01-01 – 2021-12-31
Current period

SEK 0

2022-01-01 – 2022-12-31

Exact inputs and evidence

0 − 0 = 0 SEK

0 SEK · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
0 SEK · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Isofol Medical · 2022-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Year-over-year change in Capital expenditure: 0 SEK Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 SEK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1455032 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 0 SEK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1455376 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue SEK 12.8 million 100% of revenue
Operating costs Derived SEK 180.26 million 1,409% of revenue
Operating income −SEK 167.46 million −1,309% of revenue
Tax, interest and other Derived −SEK 7.71 million −60% of revenue
Net income −SEK 159.76 million −1,248% of revenue

Cash

Operating cash flow −SEK 190.98 million −1,492% of revenue
Capital expenditure SEK 0 0% of revenue
Free cash flow Derived −SEK 190.98 million −1,492% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 602% of revenue.
2021 Operating loss: operating costs were 1,013% of revenue.
2022 Operating loss: operating costs were 1,409% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	37119000	223613000 Derived	-186494000	2498000 Derived	-188992000	-160270000 Derived	Source 2020-01-01 – 2020-12-31: 37119000 SEK Inspect Revenue Open source 2020-01-01 – 2020-12-31: -186494000 SEK Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -188992000 SEK Inspect Net Income Open source 2020-01-01 – 2020-12-31: -160270000 SEK Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: -0 SEK Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	22407000	226872000 Derived	-204465000	-4214000 Derived	-200251000	-188429000 Derived	Source 2021-01-01 – 2021-12-31: 22407000 SEK Inspect Revenue Open source 2021-01-01 – 2021-12-31: -204465000 SEK Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -200251000 SEK Inspect Net Income Open source 2021-01-01 – 2021-12-31: -188429000 SEK Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 0 SEK Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	12797000	180257000 Derived	-167460000	-7705000 Derived	-159755000	-190975000 Derived	Source 2022-01-01 – 2022-12-31: 12797000 SEK Inspect Revenue Open source 2022-01-01 – 2022-12-31: -167460000 SEK Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -159755000 SEK Inspect Net Income Open source 2022-01-01 – 2022-12-31: -190975000 SEK Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 0 SEK Inspect Capital Expenditure Open source

Amounts are exact, in SEK.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

SEK 12.8M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(SEK)	Source evidence
20202020-12-31	Revenue	37119000	Revenue: 37119000 Open source
20212021-12-31	Revenue	22407000	Revenue: 22407000 Open source
20222022-12-31	Revenue	12797000	Revenue: 12797000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-42.9% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 37119000 Open source
20212021-12-31	Year over year	-39.6%	Revenue: 22407000 Open source Revenue: 37119000 Open source
20222022-12-31	Year over year	-42.9%	Revenue: 12797000 Open source Revenue: 22407000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,308.6% 2022

Net margin -1,248.4% 2022

Free cash flow margin -1,492.3% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-502.4%	Operating Income: -186494000 Open source Revenue: 37119000 Open source
20212021-12-31	Operating margin	-912.5%	Operating Income: -204465000 Open source Revenue: 22407000 Open source
20222022-12-31	Operating margin	-1,308.6%	Operating Income: -167460000 Open source Revenue: 12797000 Open source
20202020-12-31	Net margin	-509.2%	Net Income: -188992000 Open source Revenue: 37119000 Open source
20212021-12-31	Net margin	-893.7%	Net Income: -200251000 Open source Revenue: 22407000 Open source
20222022-12-31	Net margin	-1,248.4%	Net Income: -159755000 Open source Revenue: 12797000 Open source
20202020-12-31	Free cash flow margin	-431.8%	Revenue: 37119000 Open source Operating Cash Flow: -160270000 Open source Capital Expenditure: -0 Open source
20212021-12-31	Free cash flow margin	-840.9%	Revenue: 22407000 Open source Operating Cash Flow: -188429000 Open source Capital Expenditure: 0 Open source
20222022-12-31	Free cash flow margin	-1,492.3%	Revenue: 12797000 Open source Operating Cash Flow: -190975000 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

SEK -191M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(SEK)	Source evidence
20202020-12-31	Operating cash flow	-160270000	Operating Cash Flow: -160270000 Open source
20212021-12-31	Operating cash flow	-188429000	Operating Cash Flow: -188429000 Open source
20222022-12-31	Operating cash flow	-190975000	Operating Cash Flow: -190975000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

SEK -191M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(SEK)	Source evidence
20202020-12-31	Free cash flow	-160270000	Operating Cash Flow: -160270000 Open source Capital Expenditure: -0 Open source
20212021-12-31	Free cash flow	-188429000	Operating Cash Flow: -188429000 Open source Capital Expenditure: 0 Open source
20222022-12-31	Free cash flow	-190975000	Operating Cash Flow: -190975000 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

25.8% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	55.1%	Total Liabilities: 81563000 Open source Total Assets: 148130000 Open source
20212021-12-31	Liabilities / assets	20.7%	Total Liabilities: 83130000 Open source Total Assets: 401363000 Open source
20222022-12-31	Liabilities / assets	25.8%	Total Liabilities: 54985000 Open source Total Assets: 213464000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.05× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	1.75×	Current Assets: 139841000 Open source Current Liabilities: 80124000 Open source
20212021-12-31	Current assets / current liabilities	4.75×	Current Assets: 394609000 Open source Current Liabilities: 83020000 Open source
20222022-12-31	Current assets / current liabilities	4.05×	Current Assets: 209451000 Open source Current Liabilities: 51735000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−SEK 188.99 million Exact value Exact value: -188992000 SEK 2020-01-01 – 2020-12-31: -188992000 SEK Inspect Net Income Open source Share or cite Citation for Net Income · Isofol Medical · 2020-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Net Income: -188992000 SEK Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=SEK&dimensions= Input fundies:NetIncome: -188992000 SEK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2021-12-31/ESEF/SE/0/isof-2021-12-31-sv.zip#2024866 Filing: 549300MCXYAHG7VBHX75-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	−SEK 160.27 million Exact value Exact value: -160270000 SEK 2020-01-01 – 2020-12-31: -160270000 SEK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Isofol Medical · 2020-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Operating Cash Flow: -160270000 SEK Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=SEK&dimensions= Input fundies:OperatingCashFlow: -160270000 SEK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2021-12-31/ESEF/SE/0/isof-2021-12-31-sv.zip#2076871 Filing: 549300MCXYAHG7VBHX75-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	SEK 0 Exact value Exact value: -0 SEK 2020-01-01 – 2020-12-31: -0 SEK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Isofol Medical · 2020-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Capital Expenditure: -0 SEK Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=SEK&dimensions= Input fundies:CapitalExpenditure: -0 SEK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2021-12-31/ESEF/SE/0/isof-2021-12-31-sv.zip#2077782 Filing: 549300MCXYAHG7VBHX75-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	−SEK 160.27 million Calculation and evidence -160270000 − -0 SEK Exact free cash flow: -160270000 SEK 2020-01-01 – 2020-12-31: -160270000 SEK · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: -0 SEK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Isofol Medical · 2020-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Free cash flow: -160270000 SEK Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -160270000 SEK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2021-12-31/ESEF/SE/0/isof-2021-12-31-sv.zip#2076871 Filing: 549300MCXYAHG7VBHX75-2021-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: -0 SEK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2021-12-31/ESEF/SE/0/isof-2021-12-31-sv.zip#2077782 Filing: 549300MCXYAHG7VBHX75-2021-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−SEK 200.25 million Exact value Exact value: -200251000 SEK 2021-01-01 – 2021-12-31: -200251000 SEK Inspect Net Income Open source Share or cite Citation for Net Income · Isofol Medical · 2021-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Net Income: -200251000 SEK Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=SEK&dimensions= Input fundies:NetIncome: -200251000 SEK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1387180 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	−SEK 188.43 million Exact value Exact value: -188429000 SEK 2021-01-01 – 2021-12-31: -188429000 SEK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Isofol Medical · 2021-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Operating Cash Flow: -188429000 SEK Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=SEK&dimensions= Input fundies:OperatingCashFlow: -188429000 SEK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1454195 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	SEK 0 Exact value Exact value: 0 SEK 2021-01-01 – 2021-12-31: 0 SEK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Isofol Medical · 2021-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Capital Expenditure: 0 SEK Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=SEK&dimensions= Input fundies:CapitalExpenditure: 0 SEK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1455376 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	−SEK 188.43 million Calculation and evidence -188429000 − 0 SEK Exact free cash flow: -188429000 SEK 2021-01-01 – 2021-12-31: -188429000 SEK · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 0 SEK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Isofol Medical · 2021-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Free cash flow: -188429000 SEK Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -188429000 SEK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1454195 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 0 SEK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1455376 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−SEK 159.76 million Exact value Exact value: -159755000 SEK 2022-01-01 – 2022-12-31: -159755000 SEK Inspect Net Income Open source Share or cite Citation for Net Income · Isofol Medical · 2022-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Net Income: -159755000 SEK Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=SEK&dimensions= Input fundies:NetIncome: -159755000 SEK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1386843 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	−SEK 190.98 million Exact value Exact value: -190975000 SEK 2022-01-01 – 2022-12-31: -190975000 SEK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Isofol Medical · 2022-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Operating Cash Flow: -190975000 SEK Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=SEK&dimensions= Input fundies:OperatingCashFlow: -190975000 SEK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1453857 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	SEK 0 Exact value Exact value: 0 SEK 2022-01-01 – 2022-12-31: 0 SEK Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Isofol Medical · 2022-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Capital Expenditure: 0 SEK Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=SEK&dimensions= Input fundies:CapitalExpenditure: 0 SEK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1455032 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.	−SEK 190.98 million Calculation and evidence -190975000 − 0 SEK Exact free cash flow: -190975000 SEK 2022-01-01 – 2022-12-31: -190975000 SEK · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 0 SEK · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Isofol Medical · 2022-12-31 Isofol Medical (esef:549300MCXYAHG7VBHX75) Free cash flow: -190975000 SEK Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/esef/549300MCXYAHG7VBHX75?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -190975000 SEK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1453857 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 Input fundies:CapitalExpenditure: 0 SEK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/549300MCXYAHG7VBHX75/2022-12-31/ESEF/SE/0/isof-2022-12-31-sv.zip#1455032 Filing: 549300MCXYAHG7VBHX75-2022-12-31-ESEF-SE-0 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

2 filings · 160 latest values · 160 originally reported values

Dataset published 2026-11-07. Source filing dates and reporting periods are shown separately.

Identifiers: 549300MCXYAHG7VBHX75, esef:549300MCXYAHG7VBHX75

Isofol Medical

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation